Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M011708200 on January 12, 2001

J. Biol. Chem., Vol. 276, Issue 16, 12520-12529, April 20, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/16/12520    most recent
M011708200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huppertz, C.
Right arrow Articles by Kahn, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huppertz, C.
Right arrow Articles by Kahn, B. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Uncoupling Protein 3 (UCP3) Stimulates Glucose Uptake in Muscle Cells through a Phosphoinositide 3-Kinase-dependent Mechanism*

Christine HuppertzDagger §, Britta M. FischerDagger §, Young-Bum KimDagger , Ko KotaniDagger , Antonio Vidal-PuigDagger , Lawrence J. Slieker||, Kyle W. Sloop||, Bradford B. LowellDagger , and Barbara B. KahnDagger **

From the Dagger  Diabetes Unit, Department of Medicine, Division of Endocrinology and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215 and the || Endocrine Research Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285

UCP3 is a mitochondrial membrane protein expressed in humans selectively in skeletal muscle. To determine the mechanisms by which UCP3 plays a role in regulating glucose metabolism, we expressed human UCP3 in L6 myotubes by adenovirus-mediated gene transfer and in H9C2 cardiomyoblasts by stable transfection with a tetracycline-repressible UCP3 construct. Expression of UCP3 in L6 myotubes increased 2-deoxyglucose uptake 2-fold and cell surface GLUT4 2.3-fold, thereby reaching maximally insulin-stimulated levels in control myotubes. Wortmannin, LY 294002, or the tyrosine kinase inhibitor genistein abolished the effect of UCP3 on glucose uptake, and wortmannin inhibited UCP3-induced GLUT4 cell surface recruitment. UCP3 overexpression increased phosphotyrosine-associated phosphoinositide 3-kinase (PI3K) activity 2.2-fold compared with control cells (p < 0.05). UCP3 overexpression increased lactate release 1.5- to 2-fold above control cells, indicating increased glucose metabolism. In H9C2 cardiomyoblasts stably transfected with UCP3 under control of a tetracycline-repressible promotor, removal of doxycycline resulted in detectable levels of UCP3 at 12 h and 2.2-fold induction at 7 days compared with 12 h. In parallel, glucose transport increased 1.3- and 2-fold at 12 h and 7 days, respectively, and the stimulation was inhibited by wortmannin or genistein. p85 association with membranes was increased 5.5-fold and phosphotyrosine-associated PI3K activity 3.8-fold. In contrast, overexpression of UCP3 in 3T3-L1 adipocytes did not alter glucose uptake, suggesting tissue-specific effects of human UCP3. Thus, UCP3 stimulates glucose transport and GLUT4 translocation to the cell surface in cardiac and skeletal muscle cells by activating a PI3K dependent pathway.


* This study was supported by National Institutes of Health Grants DK 43051 (to B. B. K.) and DK 49569 (to B. B. L.) and a grant from Eli Lilly.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

Supported by research fellowships from Eli Lilly/European Association for the Study of Diabetes and the American Diabetes Association.

** To whom correspondence should be addressed: Diabetes Unit, Research North 325E, Beth Israel Deaconess Medical Center, 99 Brookline Ave., Boston, MA 02215. Tel.: 617-667-5422; Fax: 617-667-2927; E-mail: bkahn@caregroup.harvard.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
C. S Wyrwoll, P. J Mark, T. A Mori, and B. J Waddell
Developmental programming of adult hyperinsulinemia, increased proinflammatory cytokine production, and altered skeletal muscle expression of SLC2A4 (GLUT4) and uncoupling protein 3
J. Endocrinol., September 1, 2008; 198(3): 571 - 579.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
V. Bezaire, E. L. Seifert, and M.-E. Harper
Uncoupling protein-3: clues in an ongoing mitochondrial mystery
FASEB J, February 1, 2007; 21(2): 312 - 324.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. D. MacLellan, M. F. Gerrits, A. Gowing, P. J.S. Smith, M. B. Wheeler, and M.-E. Harper
Physiological Increases in Uncoupling Protein 3 Augment Fatty Acid Oxidation and Decrease Reactive Oxygen Species Production Without Uncoupling Respiration in Muscle Cells
Diabetes, August 1, 2005; 54(8): 2343 - 2350.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Yvan-Charvet, P. Even, M. Bloch-Faure, M. Guerre-Millo, N. Moustaid-Moussa, P. Ferre, and A. Quignard-Boulange
Deletion of the Angiotensin Type 2 Receptor (AT2R) Reduces Adipose Cell Size and Protects From Diet-Induced Obesity and Insulin Resistance
Diabetes, April 1, 2005; 54(4): 991 - 999.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K. R Steffensen, S. Y. Neo, T. M Stulnig, V. B Vega, S. S Rahman, G. U Schuster, J.-A. Gustafsson, and E. T Liu
Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals
J. Mol. Endocrinol., December 1, 2004; 33(3): 609 - 622.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. B. Suliman, K. E. Welty-Wolf, M. Carraway, L. Tatro, and C. A. Piantadosi
Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis
Cardiovasc Res, November 1, 2004; 64(2): 279 - 288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Perdomo, S. R. Commerford, A.-M. T. Richard, S. H. Adams, B. E. Corkey, R. M. O'Doherty, and N. F. Brown
Increased {beta}-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation
J. Biol. Chem., June 25, 2004; 279(26): 27177 - 27186.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L.-J. Ma, S.-L. Mao, K. L. Taylor, T. Kanjanabuch, Y. Guan, Y. Zhang, N. J. Brown, L. L. Swift, O. P. McGuinness, D. H. Wasserman, et al.
Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1
Diabetes, February 1, 2004; 53(2): 336 - 346.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
X. Sun, C. Wray, X. Tian, P.-O. Hasselgren, and J. Lu
Expression of uncoupling protein 3 is upregulated in skeletal muscle during sepsis
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E512 - E520.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
P. Schrauwen and M. Hesselink
UCP2 and UCP3 in muscle controlling body metabolism
J. Exp. Biol., August 1, 2002; 205(15): 2275 - 2285.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. Argyropoulos and M.-E. Harper
Molecular Biology of Thermoregulation: Invited Review: Uncoupling proteins and thermoregulation
J Appl Physiol, May 1, 2002; 92(5): 2187 - 2198.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Schrauwen, M. K.C. Hesselink, E. E. Blaak, L. B. Borghouts, G. Schaart, W. H.M. Saris, and H. A. Keizer
Uncoupling Protein 3 Content Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes
Diabetes, December 1, 2001; 50(12): 2870 - 2873.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Cadenas, K. S. Echtay, J. A. Harper, M. B. Jekabsons, J. A. Buckingham, E. Grau, A. Abuin, H. Chapman, J. C. Clapham, and M. D. Brand
The Basal Proton Conductance of Skeletal Muscle Mitochondria from Transgenic Mice Overexpressing or Lacking Uncoupling Protein-3
J. Biol. Chem., January 18, 2002; 277(4): 2773 - 2778.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement